The market is heading for a shake-up, however, as Novo Nordisk is heading for the loss of patent protection for its GLP-1 agonist semaglutide in China before the end of this month, which could be followed by the entry of lower-cost generic alternatives
Side Effects and Tolerability GLP-1 medications are generally well-tolerated, with the most common side effects being gastrointestinal issues such as nausea and vomiting
Cholesterol + Hypothyroidism High cholesterol
It has been shown that PPAR inhibits ACSL4 expression and reduces lipid peroxidation, thereby preventing ferroptosis
And in fact, strength is a marker of health
Reduced motility allows bile to stagnate, which promotes cholesterol crystal formation and gallstone development